flumazenil has been researched along with triazolam in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (15.38) | 18.7374 |
| 1990's | 26 (50.00) | 18.2507 |
| 2000's | 15 (28.85) | 29.6817 |
| 2010's | 3 (5.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ananthan, S; Cook, JM; Gu, ZQ; Hunkeler, W; Koehler, KF; Schönholzer, P; Skolnick, P; Wong, G; Zhang, W | 1 |
| Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Clayton, T; Cook, J; DeLorey, TM; Furtmüller, R; Halliwell, RF; Harris, D; Huck, S; Sahbaie, P; Sieghart, W | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Facklam, M; Haefely, WE; Schoch, P | 1 |
| Bonetti, EP; Facklam, M; Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Schoch, P | 1 |
| Arbilla, S; Benavides, J; Durand, A; Peny, B; Scatton, B | 1 |
| Deng, JF; Hung, DZ; Tsai, WJ | 1 |
| Ator, NA; Griffiths, RR | 1 |
| Martin, JV; Mendelson, WB | 1 |
| Casals-Stenzel, J | 1 |
| Franklin, SR; Tang, AH | 1 |
| Burkhart, KK; Kulig, KW | 1 |
| Dunton, AW; Hendler, J; McGrath, J; Pitman, V; Schwam, E; Siegel, J | 1 |
| Greenblatt, DJ; Lopez, F; Miller, LG; Paul, SM; Shader, RI | 1 |
| Griffiths, RR; Lamb, RJ | 1 |
| Casals-Stenzel, J; Weber, KH | 1 |
| Barnhill, JG; Deutsch, SI; Greenblatt, DJ; Miller, LG; Paul, SM; Shader, RI | 1 |
| Egner, J; Kelly, C; Rubin, J | 1 |
| Turek, FW; Van Reeth, O; Vanderhaeghen, JJ | 1 |
| Bonetti, EP; Cumin, R; Haefely, WE; Scherschlicht, R | 1 |
| Amano, M; Hasegawa, T; Kitaichi, K; Minami, Y; Nabeshima, T; Yamada, K | 1 |
| Cohen, C; Sanger, DJ | 2 |
| Carter, DB; Hamilton, BJ; Im, HK; Im, WB; Vonvoigtlander, PF | 1 |
| Bottlaender, M; Brouillet, E; Crouzel, C; Fuseau, C; Le Breton, C; Mazière, M; Schmid, L; Sitbon, R; Varastet, M | 1 |
| Balkin, TJ; Belenky, GL; Davis, HQ; Wesensten, NJ | 1 |
| Meier-Abt, PJ; Radovanovic, D; Wyss, PA | 1 |
| Hadingham, KL; Palmer, KJ; Thompson, SA; Wafford, KA; Whiting, PJ | 1 |
| Besnard, F; Faure, C; Graham, D; Langer, SZ | 1 |
| Kulkarni, SK; Reddy, DS | 2 |
| Kulkarni, SK; Shaji, AV | 1 |
| Bergström, M; Långström, B; Matsumura, K; Murata, T; Onoe, H; Sihver, S; Sihver, W; Watanabe, Y; Yonekura, Y | 1 |
| Hosoi, R; Inoue, O; Kobayashi, K; Watanabe, Y | 1 |
| Bickel, WK; Smith, BJ | 1 |
| France, CP; Gerak, LR; Lelas, S | 1 |
| Cook, JM; Ma, C; Miczek, KA; Rowlett, JK; Tornatzky, W | 1 |
| Lelas, S; Rowlett, JK; Spealman, RD | 1 |
| Cook, J; Ma, C; Platt, DM; Rowlett, JK; Spealman, RD | 1 |
| Kishore, K; Saraf, MK; Sharma, A; Singh, M; Thomas, KM | 1 |
| Foster, AC; Grigoriadis, DE; Gross, RS; Petroski, RE; Sullivan, SK; Verge, G | 1 |
| Ator, NA; Griffiths, RR; Kaminski, BJ; Weerts, EM | 1 |
| Baburin, I; Hering, S; Hohaus, A; Khom, S; Sieghart, W; Timin, EN | 1 |
| Heima, M; Hosaka, K; Jackson, D; Milgrom, P; Pickrell, JE | 1 |
| Weaver, JM | 1 |
3 review(s) available for flumazenil and triazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: present status.
Topics: Animals; Azepines; Central Nervous System; Flumazenil; Humans; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Triazolam; Triazoles | 1991 |
Flumazenil: US clinical pharmacology studies.
Topics: Adult; Diazepam; Double-Blind Method; Drug Interactions; Female; Flumazenil; Humans; Lorazepam; Male; Memory; Receptors, GABA-A; Triazolam | 1988 |
5 trial(s) available for flumazenil and triazolam
| Article | Year |
|---|---|
The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology.
Topics: Adult; Alprazolam; Carbon Monoxide Poisoning; Clinical Trials as Topic; Coma; Double-Blind Method; Drug Overdose; Flumazenil; Humans; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Suicide, Attempted; Triazolam | 1990 |
Flumazenil: US clinical pharmacology studies.
Topics: Adult; Diazepam; Double-Blind Method; Drug Interactions; Female; Flumazenil; Humans; Lorazepam; Male; Memory; Receptors, GABA-A; Triazolam | 1988 |
Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.
Topics: Administration, Oral; Adolescent; Adult; Flumazenil; Humans; Hypnotics and Sedatives; Male; Memory; Placebo Effect; Pyridines; Time Factors; Triazolam; Volunteers; Zolpidem | 1995 |
Flumazenil discrimination by humans under a two-response and a novel-response procedure.
Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Modulators; Humans; Male; Midazolam; Psychomotor Performance; Triazolam | 1999 |
Flumazenil reversal of sublingual triazolam: a randomized controlled clinical trial.
Topics: Administration, Sublingual; Adolescent; Adult; Anesthesia, Dental; Antidotes; Blood Pressure; Conscious Sedation; Consciousness; Double-Blind Method; Electroencephalography; Female; Flumazenil; GABA Modulators; Heart Rate; Hemoglobins; Humans; Hypnotics and Sedatives; Injections; Male; Pilot Projects; Placebos; Time Factors; Triazolam; Young Adult | 2009 |
45 other study(ies) available for flumazenil and triazolam
| Article | Year |
|---|---|
Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors.
Topics: Animals; Azepines; Benzodiazepines; Cerebellum; Computer Simulation; Diazepam; In Vitro Techniques; Ligands; Male; Models, Molecular; Molecular Conformation; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Structure-Activity Relationship; X-Ray Diffraction | 1993 |
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
Topics: Animals; Behavior, Animal; Benzodiazepines; Chemical Phenomena; Chemistry, Physical; Computer Simulation; Databases, Factual; Electrophysiology; Female; Ligands; Male; Memory; Mice; Models, Molecular; Molecular Structure; Oocytes; Protein Isoforms; Protein Subunits; Quantitative Structure-Activity Relationship; Receptors, GABA-A; Structure-Activity Relationship; Xenopus laevis | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies.
Topics: Animals; Benzodiazepinones; Cell Membrane; Cerebral Cortex; Chlorides; Diazepam; Drug Synergism; Flumazenil; gamma-Aminobutyric Acid; Ligands; Male; Rats; Receptors, GABA-A; Triazolam | 1992 |
Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
Topics: Administration, Oral; Animals; Benzodiazepinones; Diazepam; Dose-Response Relationship, Drug; Female; Flumazenil; Male; Mice; Mice, Inbred DBA; Motor Activity; Receptors, GABA-A; Seizures; Triazolam | 1992 |
Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Topics: Animals; Benzodiazepines; Binding Sites; Binding, Competitive; Brain Chemistry; Cell Membrane; Central Nervous System; Flumazenil; Hypnotics and Sedatives; Pyridazines; Pyridines; Rats; Receptors, GABA-A; Triazolam; Zolpidem | 1992 |
Anterograde amnesia in triazolam overdose despite flumazenil treatment: a case report.
Topics: Adolescent; Amnesia; Drug Overdose; Flumazenil; Humans; Male; Suicide, Attempted; Triazolam | 1992 |
Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence.
Topics: Animals; Conditioning, Operant; Diazepam; Drinking Behavior; Ethanol; Flumazenil; Food; Half-Life; Male; Papio; Reinforcement Schedule; Reward; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1992 |
Characterization of the hypnotic effects of triazolam microinjections into the medial preoptic area.
Topics: Body Temperature; Brain Mapping; Flumazenil; Hypnotics and Sedatives; Microinjections; Preoptic Area; Sleep; Triazolam | 1992 |
The discriminative stimulus effects of diazepam in rats at two training doses.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Buspirone; Carbolines; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Flumazenil; Male; Morphine; Pentobarbital; Pyrazoles; Pyridazines; Rats; Rats, Inbred Strains; Triazolam | 1991 |
Low-dose alprazolam augments motor activity in mice.
Topics: Alprazolam; Animals; Clonazepam; Exploratory Behavior; Flumazenil; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, GABA-A; Triazolam | 1988 |
Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Convulsants; Diazepam; Drug Tolerance; Flumazenil; Humans; Male; Papio; Posture; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor; Triazolam; Vomiting | 1985 |
Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity.
Topics: Animals; Anti-Anxiety Agents; Azepines; Benzodiazepinones; Central Nervous System; Flumazenil; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Receptors, GABA-A; Tidal Volume; Triazolam | 1987 |
Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Brain; Cerebral Cortex; Estazolam; Flumazenil; Hippocampus; Hypothalamus; Kinetics; Male; Mice; Receptors, GABA-A; Triazolam | 1987 |
Successful treatment of triazolam overdose with Ro 15-1788 (Anexate)
Topics: Child, Preschool; Female; Flumazenil; Humans; Infusions, Intravenous; Triazolam | 1988 |
A benzodiazepine antagonist, Ro 15-1788, can block the phase-shifting effects of triazolam on the mammalian circadian clock.
Topics: Animals; Benzodiazepines; Circadian Rhythm; Cricetinae; Flumazenil; Male; Mesocricetus; Motor Activity; Triazolam | 1988 |
Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Cats; Diazepam; Female; Flumazenil; Humans; Lorazepam; Male; Mice; Rats; Saimiri; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1982 |
The attenuation of suppression of motility by triazolam in the conditioned fear stress task is exacerbated by ethanol in mice.
Topics: Animals; Chlordiazepoxide; Conditioning, Classical; Drug Synergism; Electric Stimulation; Ethanol; Fear; Flumazenil; Learning; Male; Mice; Motor Activity; Pain Threshold; Receptors, GABA-A; Stress, Psychological; Triazolam | 1995 |
Effects of chronic treatment with triazolam on operant responding in rats.
Topics: Animals; Conditioning, Operant; Drug Tolerance; Flumazenil; Hypnotics and Sedatives; Male; Pyridines; Rats; Rats, Wistar; Reinforcement Schedule; Time Factors; Triazolam; Zolpidem | 1994 |
Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps.
Topics: Animals; Anti-Anxiety Agents; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Tolerance; Flumazenil; Infusion Pumps; Male; Rats; Rats, Wistar; Receptors, GABA-A; Reinforcement Schedule; Substance-Related Disorders; Triazolam | 1994 |
Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors.
Topics: Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazepines; Binding Sites; Cells, Cultured; Chloride Channels; Cloning, Molecular; Drug Synergism; Flumazenil; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Imidazoles; Kidney; Kinetics; Membrane Potentials; Piperazines; Pyridazines; Pyridines; Receptors, GABA-A; Triazolam | 1993 |
In vivo high intrinsic efficacy of triazolam: a positron emission tomography study in nonhuman primates.
Topics: Animals; Anticonvulsants; Blood; Brain; Flumazenil; Ligands; Male; Papio; Receptors, GABA-A; Tomography, Emission-Computed; Triazolam | 1994 |
[Acute overdose of Zolpidem (Stilnox)].
Topics: Adolescent; Adult; Aged; Antidotes; Coma; Drug Overdose; Female; Flumazenil; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Pyridines; Retrospective Studies; Triazolam; Zolpidem | 1996 |
Expression and pharmacology of human GABAA receptors containing gamma 3 subunits.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Base Sequence; Benzodiazepines; Benzodiazepinones; Carbolines; Flumazenil; Flunitrazepam; GABA Modulators; Humans; Molecular Sequence Data; Pyrazoles; Pyridazines; Pyridines; Receptors, GABA-A; Recombinant Proteins; Sequence Homology, Amino Acid; Triazolam; Xenopus; Zolpidem | 1995 |
Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Cell Line; Flumazenil; GABA Modulators; Humans; Rats; Receptors, GABA-A; Recombinant Proteins; Transfection; Triazolam | 1996 |
Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice.
Topics: Analysis of Variance; Animals; Ascorbic Acid; Behavior, Animal; Binding Sites; Cerebellum; Cerebral Cortex; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA Antagonists; GABA Modulators; Isoquinolines; Male; Mice; Mitochondria; Motor Activity; Pain Measurement; Picrotoxin; Progesterone; Receptors, GABA-A; RNA; Stress, Psychological; Triazolam | 1996 |
Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Calcium Channel Blockers; Dose-Response Relationship, Drug; Flumazenil; GABA Antagonists; GABA Modulators; Isoquinolines; Male; Mice; Mice, Inbred BALB C; Motor Activity; Nifedipine; Picrotoxin; Reaction Time; Steroids; Triazolam | 1997 |
Evidence of GABAergic modulation in melatonin-induced short-term memory deficits and food consumption.
Topics: Animals; Antioxidants; Diazepam; Eating; Female; Flumazenil; GABA Modulators; Latency Period, Psychological; Male; Maze Learning; Melatonin; Memory Disorders; Memory, Short-Term; Mice; Muscarinic Antagonists; Rats; Rats, Wistar; Receptors, GABA; Scopolamine; Triazolam | 1998 |
Triazolam-induced modulation of muscarinic acetylcholine receptor in living brain slices as revealed by a new positron-based imaging technique.
Topics: Animals; Brain; Flumazenil; GABA Agonists; In Vitro Techniques; Male; Muscimol; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Tomography, Emission-Computed; Triazolam | 1998 |
Discrepancy of benzodiazepine receptor occupancy between 3H-flumazenil and 125I-iomazenil in intact mouse brain.
Topics: Animals; Binding, Competitive; Brain; Carbolines; Flumazenil; Flunitrazepam; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Male; Mice; Nitrazepam; Receptors, GABA-A; Triazolam; Tritium | 1999 |
Discriminative-stimulus effects of triazolam and midazolam in rhesus monkeys.
Topics: Animals; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Modulators; Generalization, Stimulus; Hypnotics and Sedatives; Macaca mulatta; Male; Midazolam; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule; Triazolam | 1999 |
Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Body Temperature; Carbolines; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA-A Receptor Antagonists; Mice; Pyridines; Receptors, GABA-A; Triazolam; Vocalization, Animal; Zolpidem | 2001 |
Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs.
Topics: Animals; Anti-Anxiety Agents; Barbiturates; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Male; Receptors, GABA-A; Saimiri; Triazolam | 2001 |
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Topics: Animals; Ataxia; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Antagonists; Male; Motor Activity; Pyridines; Receptors, GABA-A; Saimiri; Social Behavior; Triazolam; Zolpidem | 2002 |
Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Amnesia, Anterograde; Amnesia, Retrograde; Animals; Anti-Anxiety Agents; Azepines; Diazepam; Diterpenes; Escape Reaction; Female; Flumazenil; Ginkgolides; Lactones; Learning; Male; Mice; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Reaction Time; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, GABA-A; Retention, Psychology; Triazolam | 2003 |
Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
Topics: Acetamides; Animals; Azides; Benzodiazepines; Binding Sites; Brain; Cell Membrane; Cerebellum; Cerebral Cortex; Chloride Channels; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Kinetics; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Thiophenes; Triazolam; Tritium; Zolpidem | 2004 |
Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons.
Topics: Animals; Behavior, Animal; Benzodiazepinones; Dose-Response Relationship, Drug; Eating; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Infusions, Parenteral; Male; Papio; Psychomotor Performance; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 2005 |
Pharmacological properties of GABAA receptors containing gamma1 subunits.
Topics: Animals; Azepines; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Midazolam; Oocytes; Protein Subunits; Pyrazoles; Receptors, GABA-A; Triazolam; Xenopus laevis | 2006 |
The fallacy of a lifesaving sublingual injection of flumazenil.
Topics: Anesthesia Recovery Period; Antidotes; Benzodiazepines; Conscious Sedation; Drug Overdose; Flumazenil; GABA Modulators; Humans; Hypnotics and Sedatives; Hypoxia, Brain; Injections; Injections, Intramuscular; Injections, Intravenous; Midazolam; Receptors, GABA-A; Respiration, Artificial; Triazolam | 2011 |